Clinical Trial

Surgical Versus Percutaneous Revascularization in Patients With Reduced Left Ventricular Function (STICH 3.0-NL)

Study acronym: STICH 3*0-NL
Recruiting
View on ClinicalTrials.gov →
Summary
This randomized multicenter trial compares coronary artery bypass grafting (CABG) with percutaneous coronary intervention (PCI) in 358 patients with ischemic left ventricular dysfunction and multivessel coronary disease. The study evaluates differences in survival, major cardiovascular events, and quality of life over 4 years, and contributes to the international STICH 3.0 collaboration assessing long-term outcomes.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-12-05.
Status change: Not Yet Recruiting → Recruiting 2026-05-07
Trial Details
NCT Number NCT07269366
Lead Sponsor University Medical Center Groningen
Collaborators: Dutch Heart Foundation
Conditions Coronary Artery Disease, Coronary Artery Disease (CAD), Multivessel Coronary Artery Disease, CABG, CABG in Low EF, Heart Failure, PCI, Revascularization
Enrollment 358 participants
Start Date 2026-05
Primary Completion 2034-05 (estimated)
Study Completion 2034-05 (estimated)
Updated on ClinicalTrials.gov 2026-05-12